(Q77995492)

English

Antigen-specific cytotoxicity and cell number of adoptively transferred T cells are efficiently maintained in vivo by re-stimulation with an antigen/interleukin-2 fusion protein

scientific article published on 01 August 1999

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404072%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Antigen-specific cytotoxicity and cell number of adoptively transferred T cells are efficiently maintained in vivo by re-stimulation with an antigen/interleukin-2 fusion protein (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404072%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

B Y Kang

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404072%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Y S Lim

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404072%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

S W Chung

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404072%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

E J Kim

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404072%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

S H Kim

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404072%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

S Y Hwang

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404072%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

T S Kim

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404072%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

language of work or name

0 references

publication date

1 August 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404072%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

number of pages

5

1 reference

based on heuristic

inferred from page(s)

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404072%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

82

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404072%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404072%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

569-573

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404072%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C569%3A%3AAID-IJC16%3E3.0.CO%3B2-M

21 January 2018

Cancer Tumor antigens

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C569%3A%3AAID-IJC16%3E3.0.CO%3B2-M

21 January 2018

Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C569%3A%3AAID-IJC16%3E3.0.CO%3B2-M

21 January 2018

Biological activity and in vivo clearance of antitumor antibody/cytokine fusion proteins

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C569%3A%3AAID-IJC16%3E3.0.CO%3B2-M

21 January 2018

Human tumor antigens recognized by T-cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C569%3A%3AAID-IJC16%3E3.0.CO%3B2-M

21 January 2018

Immunization with interleukin-2-secreting allogeneic mouse fibroblasts expressing melanoma-associated antigens prolongs the survival of mice with melanoma.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C569%3A%3AAID-IJC16%3E3.0.CO%3B2-M

21 January 2018

The immunotherapy of human cancer with interleukin 2: present status and future directions

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C569%3A%3AAID-IJC16%3E3.0.CO%3B2-M

21 January 2018

Potentiation of antigen-specific, Th1 immune responses by multiple DNA vaccination with an ovalbumin/interferon-gamma hybrid construct

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C569%3A%3AAID-IJC16%3E3.0.CO%3B2-M

21 January 2018

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C569%3A%3AAID-IJC16%3E3.0.CO%3B2-M

21 January 2018

Toxicity and therapeutic efficacy of high-dose interleukin 2. In vivo infusion of antibody to NK-1.1 attenuates toxicity without compromising efficacy against murine leukemia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C569%3A%3AAID-IJC16%3E3.0.CO%3B2-M

21 January 2018

Systemic T cell adoptive immunotherapy of malignant gliomas

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C569%3A%3AAID-IJC16%3E3.0.CO%3B2-M

21 January 2018

Acute immunologic effects of interleukin-2 therapy in cancer patients: decreased delayed type hypersensitivity response and decreased proliferative response to soluble antigens

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C569%3A%3AAID-IJC16%3E3.0.CO%3B2-M

21 January 2018

Prospects for adoptive T cell therapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C569%3A%3AAID-IJC16%3E3.0.CO%3B2-M

21 January 2018

Identifiers

10.1002/(SICI)1097-0215(19990812)82:4<569::AID-IJC16>3.0.CO;2-M

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404072%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404072%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77995492&oldid=1773990259"